These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18500268)

  • 1. Expression of alpha-methylacyl coenzyme A racemase in the dysplasia carcinoma sequence associated with Barrett's esophagus.
    Scheil-Bertram S; Lorenz D; Ell C; Sheremet E; Fisseler-Eckhoff A
    Mod Pathol; 2008 Aug; 21(8):961-7. PubMed ID: 18500268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
    Dorer R; Odze RD
    Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of α-methylacyl-CoA racemase immunochemistry for predicting neoplastic progression in Barrett's oesophagus.
    Kastelein F; Biermann K; Steyerberg EW; Verheij J; Kalisvaart M; Looijenga LH; Stoop HA; Walter L; Kuipers EJ; Spaander MC; Bruno MJ;
    Histopathology; 2013 Nov; 63(5):630-9. PubMed ID: 24004067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of indefinite for dysplasia in Barrett's oesophagus: reproducibility of diagnosis, clinical outcomes and predicting progression with AMACR (alpha-methylacyl-CoA-racemase).
    Sonwalkar SA; Rotimi O; Scott N; Verghese E; Dixon M; Axon AT; Everett SM
    Histopathology; 2010 Jun; 56(7):900-7. PubMed ID: 20636793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of alpha-methylacyl-coenzyme A racemase in dysplastic Barrett's epithelium.
    Lisovsky M; Falkowski O; Bhuiya T
    Hum Pathol; 2006 Dec; 37(12):1601-6. PubMed ID: 16996568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-phosphorylated histone H3 expression in Barrett's esophagus, low-grade dysplasia, high-grade dysplasia, and adenocarcinoma.
    Goodarzi M; Correa AM; Ajani JA; Swisher SG; Hofstetter WL; Guha S; Deavers MT; Rashid A; Maru DM
    Mod Pathol; 2009 Dec; 22(12):1612-21. PubMed ID: 19734842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 is expressed frequently and early in Barrett's oesophagus and associated adenocarcinoma.
    Lagorce C; Paraf F; Vidaud D; Couvelard A; Wendum D; Martin A; Fléjou JF
    Histopathology; 2003 May; 42(5):457-65. PubMed ID: 12713622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-methylacyl-CoA-racemase expression in adenocarcinoma, dysplasia and non-neoplastic epithelium of the stomach.
    Lee WA
    Oncology; 2006; 71(3-4):246-50. PubMed ID: 17652945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16, cyclin D1, Ki-67, and AMACR as markers for dysplasia in Barrett esophagus.
    Shi XY; Bhagwandeen B; Leong AS
    Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):447-52. PubMed ID: 18665038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. a-Methylacyl coenzyme A racemase is highly expressed in the intestinal-type adenocarcinoma and high-grade dysplasia lesions of the stomach.
    Huang W; Zhao J; Li L; Huang Y; Yang X; Wang J; Zhang T
    Histol Histopathol; 2008 Nov; 23(11):1315-20. PubMed ID: 18785113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase expression by Barrett's epithelium and during esophageal carcinoma progression.
    Brun R; Naroditsky I; Waterman M; Ben-Izhak O; Groisman G; Ilan N; Vlodavsky I
    Mod Pathol; 2009 Dec; 22(12):1548-54. PubMed ID: 19749739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross sectional study of p504s, CD133, and Twist expression in the esophageal metaplasia dysplasia adenocarcinoma sequence.
    Ahmad J; Arthur K; Maxwell P; Kennedy A; Johnston BT; Murray L; McManus DT
    Dis Esophagus; 2015 Apr; 28(3):276-82. PubMed ID: 24612412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of inflammatory secretory phospholipase A2 and cytosolic phospholipase A2 in premalignant and malignant Barrett's oesophagus.
    Lagorce-Pagès C; Paraf F; Wendum D; Martin A; Fléjou JF
    Virchows Arch; 2004 May; 444(5):426-35. PubMed ID: 15045585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study.
    Beales IL; Ogunwobi O; Cameron E; El-Amin K; Mutungi G; Wilkinson M
    BMC Cancer; 2007 Jun; 7():97. PubMed ID: 17559672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMP3 Immunoreactivity is More Sensitive Than AMACR in Detecting Dysplastic Epithelium and Early Adenocarcinoma in Barrett Esophagus.
    Gadara MR; Gonzalez M; Cartun RW; Ligato S
    Appl Immunohistochem Mol Morphol; 2017 Jul; 25(6):386-391. PubMed ID: 26766126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus.
    Geisinger KR; Teot LA; Richter JE
    Cancer; 1992 Jan; 69(1):8-16. PubMed ID: 1727677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence.
    Morris CD; Armstrong GR; Bigley G; Green H; Attwood SE
    Am J Gastroenterol; 2001 Apr; 96(4):990-6. PubMed ID: 11316217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines: evidence for a noninvasive treatment of high-grade dysplasia.
    Inge LJ; Fowler AJ; Paquette KM; Richer AL; Tran N; Bremner RM
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):531-8. PubMed ID: 23142123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysplasia in Random Biopsies from Barrett's Surveillance Is an Important Marker for More Severe Pathology.
    Noordzij IC; Van Loon van de Ende MCM; Curvers WL; van Lijnschoten G; Huysentruyt CJ; Schoon EJ
    Dig Dis Sci; 2021 Jun; 66(6):1957-1964. PubMed ID: 32661766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma.
    Morales CP; Lee EL; Shay JW
    Cancer; 1998 Aug; 83(4):652-9. PubMed ID: 9708927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.